Identifying genotype-dependent efficacy of single and combined PI3K- and 
MAPK-pathway inhibition in cancer

Sos, Martin L.; Fischer, Stefanie; Ullrich, Roland; Peifer, Martin; Heuckmann, Johannes M.; Koker, Mirjam; Heynck, Stefanie; Stückrath, Isabel; Weiss, Jonathan; Fischer, Florian; Michel, Kathrin; Goel, Aviva; Regales, Lucia; Politi, Katerina A.; Perera, Samanthi; Getlik, Matthäus; Heukamp, Lukas C.; Ansén, Sascha; Zander, Thomas; Beroukhim, Rameen; Kashkar, Hamid; Shokat, Kevan M.; Sellers, William R.; Rauh, Daniel; Orr, Christine; Hoeflich, Klaus P.; Friedman, Lori; Wong, Kwok-Kin; Pao, William; Thomas, Roman K.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer

MPS-Authors

Getlik, Matthäus
Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons98721

Rauh, Daniel
Chemical Genomics Center of the MPS, Max Planck Institute of Molecular Physiology, Max Planck Society;

Thomas, Roman K.
Max Planck Institute of Molecular Physiology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Sos, M. L., Fischer, S., Ullrich, R., Peifer, M., Heuckmann, J. M., Koker, M., et al. (2009). Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. Proceedings of the National Academy of Sciences of the United States of America, 106(43): 1, pp. 18351-18356. Retrieved from http://www.pnas.org/content/106/43/18351.abstract.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0014-02C6-0

Abstract

There is no abstract available